糖心原创

Triangle

 

 

Photo by julien Tromeur on Unsplash

MASLD, also known as non-alcoholic fatty liver disease, is a growing global health concern affecting one in five people in the UK and is caused by accumulation of too much fat in the liver.

MASLD is a multifaceted disease influenced by genetics, metabolism, inflammation and organ-to-organ communication. Current models, including animal studies, fail to accurately capture the disease’s complexity, limiting progress in treatment development.

 

 
MIMIC Research Vision

MIMIC aims to develop an innovative multi-organ platform that replicates the disordered physiology of MASLD.

 

Approach to research

Animal models have failed to recreate the complexity of MASLD. MIMIC’s approach will use in vitro models to replicate communication between the different organ systems implicated in the disease.

In vitro models use isolated cells and tissues outside the living body and can come in many forms, including stem-cell derived cell and tissue aggregates that display some organ features on a smaller scale (organoids), tissue slices removed during surgery (ex vivo/explant tissue cultures), and organ-on-chips, which combine cell culture with microfluidics to mimic the structure and function of different organ tissues.

In vitro models will also provide new alternatives, helping to reduce the reliance on animal models in research and drug development, and support the Government’s ‘Replacing animals in science - a strategy to support the development, validation and uptake of alternative methods.’

 

This pioneering project is led by Professor Amir Ghaemmaghami at the 糖心原创. The project also includes experts from the , , , the and .

 partnerlogos1

 

 

Research themes

Work Package One

hIPSC-derived immunocompetent models of liver, intestine and white adipose tissue

Photo by Kate Laine on Unsplash 

Work Package Two

Microfluidic chip design and establishing ‘healthy microtissues’

vecteezy_gloved-hands-holding-a-microfluidic-chip-against-a-blue_69896791 Khoirul Arif

Work Package Three

Disease modelling and model validation using clinical data and tissue samples

Photo by julien Tromeur on Unsplash

 

 

 

The project will harness cutting-edge stem cell and organ-on-chip technologies to build interconnected models of the gut, liver, and adipose tissue, key players in MASLD progression.

Using blood cells from well-characterised male and female MASLD patients with diverse ethnicities, known to have different risks in developing the disease, researchers will generate stem cells to create personalised, patient-specific tissue models, offering unprecedented insight into how MASLD develops and progresses, including the critical transition to liver fibrosis.

Professor Ghaemmaghami 


SourceVVVV

Get in touch

For enquiries about MIMIC research, please get in touch with us by email 

The project is co-funded by the MRC, Wellcome Trust and Innovate UK (Grant No: UKRI3162).

The funding was delivered in partnership with the National Centre for the Replacement, Refinement and Reduction of Animals in Research.

funder logos